SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-089463
Filing Date
2022-08-12
Accepted
2022-08-11 17:46:28
Documents
15
Period of Report
2022-08-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2222808d3_8k.htm   iXBRL 8-K 35253
2 EXHIBIT 1.1 tm2222808d3_ex1-1.htm EX-1.1 303045
3 EXHIBIT 5.1 tm2222808d3_ex5-1.htm EX-5.1 55861
7 GRAPHIC tm2222808d3_ex5-1img001.jpg GRAPHIC 24667
  Complete submission text file 0001104659-22-089463.txt   693057

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vrna-20220810.xsd EX-101.SCH 3045
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrna-20220810_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrna-20220810_pre.xml EX-101.PRE 22603
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2222808d3_8k_htm.xml XML 3720
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38067 | Film No.: 221157130
SIC: 2834 Pharmaceutical Preparations